Scholarly Index
Gene Colice
AstraZeneca (United States); 11,196 total citations; 291 total publications; best world rank #193
AstraZeneca (United States)
11,196Total citations
291Total publications
53H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Asthma and respiratory diseases | Lifetime | 558 | US 206 | 98.71 |
| Inhalation and Respiratory Drug Delivery | Lifetime | 193 | US 77 | 98.37 |
| Tracheal and airway disorders | Lifetime | 631 | US 335 | 98.01 |
| Respiratory and Cough-Related Research | Lifetime | 269 | US 91 | 98.33 |
| Chronic Obstructive Pulmonary Disease (COPD) Research | Lifetime | 760 | US 248 | 97.72 |
| Pharmacological Effects and Assays | Lifetime | 442 | US 160 | 95.01 |
| Vascular Anomalies and Treatments | Lifetime | 894 | US 318 | 82.87 |
| Asthma and respiratory diseases | 2021-2025 | 238 | US 66 | 97.79 |
| Allergic Rhinitis and Sensitization | 2021-2025 | 401 | US 102 | 93.59 |
| Respiratory and Cough-Related Research | 2021-2025 | 233 | US 48 | 92.03 |
| IL-33, ST2, and ILC Pathways | 2021-2025 | 290 | US 101 | 87.16 |
| Dermatology and Skin Diseases | 2021-2025 | 809 | US 185 | 88.89 |
| Inhalation and Respiratory Drug Delivery | 2021-2025 | 326 | US 70 | 87.52 |
| Pharmaceutical studies and practices | 2021-2025 | 434 | US 144 | 83.78 |